Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/1998
06/10/1998EP0846265A1 Methods for g protein coupled receptor activity screening
06/10/1998EP0846171A2 Chromosome 1 gene and gene products related to alzheimer's disease
06/10/1998EP0846116A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
06/10/1998EP0846114A1 3-pyridyloxyalkyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
06/10/1998EP0846108A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
06/10/1998EP0845990A1 New use of pregnane-diones as analgesic agents
06/10/1998EP0845989A2 Pain-alleviating drug composition and method for alleviating pain
06/10/1998EP0845988A1 Novel fused isoquinolines as dopamine receptor ligands
06/10/1998EP0746317B1 Sublingual or buccal pharmaceutical composition
06/10/1998EP0603229B1 Quinuclidine esters process and intermediates for their preparation and pharmaceutical compositions containing them
06/10/1998DE19650975A1 Neue heterocyclisch substituierte Benzamide und deren Anwendung New heterocyclic-substituted benzamides and their application
06/10/1998DE19644998C1 Verwendung von Adamantanaminen oder strukturanaloger Verbindungen zur Bekämpfung von Borna Disease Virus und zur Prophylaxe und Behandlung von Affekterkrankungen und anderen mit BDV-Infektionen verbundenen Störungen bei Mensch und Tier Use of adamantane structure or analogous compounds to combat Borna disease virus and for the prophylaxis and treatment of affective disorders and other disorders associated with BDV infections in humans and animals
06/10/1998CN1184469A 1 -phenylpyrazole-3 -carboxamides acting on neurotensin receptors
06/10/1998CN1184429A Pharmaceutical compositions for the treatment of alcohol addiction
06/10/1998CN1184425A 5 -substituted -3 -(1, 2, 3, 6 -tetrahydro -pyridin -4 -yl) - and 3 -(piperidin -4 -yl) -1h -indoles: new 5 -HT1f agonists
06/10/1998CN1184422A Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
06/10/1998CN1184254A Modulation of LC132 (opioid -like) receptor function
06/10/1998CN1038681C Producing process for triazole derivative
06/09/1998US5763614 1,4-dihydropyridine derivatives and methods of producing the same
06/09/1998US5763494 Pharmaceutical compositions comprising isovaleramide
06/09/1998US5763484 Metabolites of linoleic acid and a-linolenic acid
06/09/1998US5763476 Sublingual or buccal pharmaceutical composition
06/09/1998US5763471 Melatoninergic agonist spiro indolepyrrolidine! derivatives, process for their preparation and their use as medicinal products
06/09/1998US5763460 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-htia receptor antagonists
06/09/1998US5763459 5-ht receptor antagonist
06/09/1998US5763458 1-phenylalkanone 5-HT4 receptor ligands
06/09/1998US5763457 Method for treating anxiety
06/09/1998US5763452 Nonsteroid antiarthritic antiinflammatory agents
06/09/1998US5763448 Schizophrenia
06/09/1998US5763445 Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
06/09/1998US5763444 Central nervous system agents
06/09/1998US5763437 Benzodiazepine derivatives
06/09/1998US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof
06/09/1998US5763393 Ability to bind n-methylasperate receptors; treatment fornervous system disorders
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/09/1998US5763214 Fibroblast growth factor 11
06/09/1998US5763213 Sensory and motor neuron derived factor (SMDF)
06/09/1998US5762953 Memory function
06/09/1998US5762922 Antioxidants and intracellular gluthathione raising agents for therapeutic treatments
06/09/1998CA2111223C Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity
06/05/1998CA2223317A1 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
06/04/1998WO1998023749A1 Fibroblast growth factor-13
06/04/1998WO1998023743A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof
06/04/1998WO1998023644A1 Peptide derivatives
06/04/1998WO1998023636A1 Heptapeptide oxytocin analogues
06/04/1998WO1998023611A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023610A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023609A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023603A1 Dimesylate salts of neuropeptide y ligands
06/04/1998WO1998023596A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023591A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023587A1 5-cyclo indole compounds as 5-ht1d receptor ligands
06/04/1998WO1998023581A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/04/1998WO1998023278A1 Medicines for treating dementia or cognitive disorder, which comprises asiatic acid derivatives
06/04/1998WO1998023273A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
06/04/1998WO1998017325A3 Covalent polar lipid conjugates for targeting
06/04/1998WO1998010762A3 Controlled release dosage form of r-(z)-alpha-methoxyimino-alpha-(1-azabicyclo2.2oct-c-yl)acetonitrile monohydrochloride
06/04/1998CA2274143A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof
06/04/1998CA2272683A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2272644A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2272388A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/04/1998CA2272239A1 Fibroblast growth factor-13
06/04/1998CA2266605A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
06/04/1998CA2223541A1 New imidazoline derivatives, preparation process and the pharmaceutical compositions containing them
06/03/1998EP0845036A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/03/1998EP0845035A2 Urocortin peptides
06/03/1998EP0845034A1 Nucleic acid molecules encoding peptides having pronociceptive properties
06/03/1998EP0845003A1 Novel opioid peptides
06/03/1998EP0844996A1 Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives
06/03/1998EP0683767B1 Azacyclic compounds, compositions containing them and their use as tachykinin antagonists
06/03/1998CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition
06/03/1998CN1183781A Novel heterocyclic compounds
06/03/1998CN1183768A Benzyl piepridine derivs as pharmaceutical agents
06/03/1998CN1183765A Phenoxyethyamine derivs. having high affinity for 5 -HT1A receptor, preparation thereof, use thereof as drugs, and pharmaceutical composition contg. said derivs
06/03/1998CN1183763A Tetralines bearing phenyl substituant on aromatic ring and their use in treatment of epilepsy, stroke and brain or spinal trauma
06/03/1998CN1183726A Synthetic cryptophycins
06/03/1998CN1183722A Use of penciclovir for treatment of human herpes-virus-8
06/03/1998CN1183719A Use of imidazo £1, 2-a| pyridine -3 -acetamide derivs. for therapeutic treatment of neuropsychiatric syndromes associated with disfunction of neural circuits of basal ganglia
06/02/1998US5760276 Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
06/02/1998US5760248 Having improved metabolic stability
06/02/1998US5760225 Certain pyrazole derivatives as corticotropin-releasing factor receptor CRF1 specific ligands
06/02/1998US5760224 Antidepressants for treating psychological disorders
06/02/1998US5760184 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
06/02/1998US5760180 Kits and dna(cdna) codes and cloning expression vectors
06/02/1998US5760074 Central nervous system disorders
06/02/1998US5760073 Treatment of central nervous system disorders
06/02/1998US5760071 An urea or thiourea compounds for treating melatoninergic system disorder, sleep disorder
06/02/1998US5760068 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
06/02/1998US5760061 Using a benzothiophene compound
06/02/1998US5760059 Indole derivatives
06/02/1998US5760057 Anticoagulants
06/02/1998US5760051 Central nervous system
06/02/1998US5760037 Derivatives of N'N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene diamine and the use thereof in pharmaceutical and cosmetic compostions
06/02/1998US5760035 Piperidine compounds substituted with an aminoalkyl group and an aryloxyalkyl group, antiallergens, antiinflammatory agents, immunosuppressants
06/02/1998US5760018 Treatment of pain, inflammation, migraine, emesis
06/02/1998US5760002 Analgesics
06/02/1998US5759775 Hybridization; amplification
06/02/1998US5759585 Plasmalogen compositions and their use in neurodegenerative diseases treatment
06/02/1998US5759548 Using plant extract
06/02/1998CA2158632C Catechol diether compounds as inhibitors of tnf release
1 ... 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 ... 1833